BIOSENSORS INTERNATIONAL ANNOUNCES ENROLLMENT OF FIRST PATIENT IN PIVOTAL TRIAL OF NEW CORONARY MICROCATHETER - "BIOMICS".
The BIOMICS study is a prospective, multi-center evaluation of the safety and effectiveness of the Biosensors Microcatheter in patients undergoing Percutaneous Coronary Intervention (PCI) for the treatment of chronic total occlusions (CTO).
Absorbent stents
Drug-Eluting
Covered Stent
Bare Metal